<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 4 Issue 1</issue_number>
<issue_period>2013 (January - March)</issue_period>
<title>FORMULATION AND EVALUATION OF CYCLODEXTRINS BASED CARVEDILOL SOLID INCLUSION COMPLEXES BY LYOPHILIZATION METHOD </title>
<abstract>Cyclodextrins are cyclic (α-1, 4)-linked oligosaccharides β-D-glucopyranose containing a relatively hydrophobic central cavity and hydrophilic outer surface, which have been extensively used to increase aqueous solubility of carvedilol (CVD). The phase solubility of the drug indicated the formation of 1:1 Molar and 1:2 Molar inclusion complexes in solution with β-cyclodextrin (β-CD) and 2-hydroxy-propyl-β-cyclodextrin (HP-β-CD). The solid complexes were prepared by Lyophilization method and characterized by differential scanning calorimetry (DSC), FTIR, Scanning electron microscopy (SEM) and UV-Spectrophotometry. Complexes were analyzed for drug content and the increment in the aqueous solubility. Carvedilol was found to be 17.5 times and 34.16 times greater in β-CD-CVD complex and HP-β-CD-CVD complex (in 1:2 Molar) respectively, than pure drug alone. The solubility of HP-β-CD-CVD in 1:1 Molar was found to be 2.05 times increment than β-Cyclodextrin-drug complex and 1.952 times more in HP-β-CD-CVD complex in 1:2 Molar than β-CD-CVD complex. Thus, the cyclodextrins provided significant increment in aqueous solubility of drug molecule.</abstract>
<authors>GITA CHAURASIA</authors>
<keywords>Cyclodextrins, solubilization, Inclusion complex, Carvedilol, Solubility</keywords>
<pages>612-620</pages>
</article>
</Journal>
